-
1
-
-
84863707351
-
Cancer treatment and survivorship statistics, 2012
-
PID: 22700443
-
Siegel R, DeSantis C, Virgo K, Stein K, Mariotto A, Smith T, et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin. 2012;62(4):220–41. doi:10.3322/caac.21149.
-
(2012)
CA Cancer J Clin
, vol.62
, Issue.4
, pp. 220-241
-
-
Siegel, R.1
DeSantis, C.2
Virgo, K.3
Stein, K.4
Mariotto, A.5
Smith, T.6
-
2
-
-
71949086203
-
Caring for patients with cancer histories in community-based primary care settings: a survey of primary care physicians in the southeastern US
-
Burg MA, Grant K, Hatch R. Caring for patients with cancer histories in community-based primary care settings: a survey of primary care physicians in the southeastern US. Prim Health Care Res Dev. 2005;6(03):244–50. doi:10.1191/1463423605pc250oa.
-
(2005)
Prim Health Care Res Dev
, vol.6
, Issue.3
, pp. 244-250
-
-
Burg, M.A.1
Grant, K.2
Hatch, R.3
-
3
-
-
78650339362
-
Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study
-
PID: 21169259
-
O’Brien KM, Cole SR, Tse CK, Perou CM, Carey LA, Foulkes WD, et al. Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res. 2010;16(24):6100–10. doi:10.1158/1078-0432.CCR-10-1533.
-
(2010)
Clin Cancer Res
, vol.16
, Issue.24
, pp. 6100-6110
-
-
O’Brien, K.M.1
Cole, S.R.2
Tse, C.K.3
Perou, C.M.4
Carey, L.A.5
Foulkes, W.D.6
-
4
-
-
19344364880
-
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials
-
Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet. 2005;365(9472):1687–717. doi:10.1016/S0140-6736(05)66544-0
-
(2005)
Lancet
, vol.365
, Issue.9472
, pp. 1687-1717
-
-
-
5
-
-
79959325702
-
Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer
-
PID: 21606426
-
Neugut AI, Subar M, Wilde ET, Stratton S, Brouse CH, Hillyer GC, et al. Association between prescription co-payment amount and compliance with adjuvant hormonal therapy in women with early-stage breast cancer. J Clin Oncol. 2011;29(18):2534–42. doi:10.1200/JCO.2010.33.3179.
-
(2011)
J Clin Oncol
, vol.29
, Issue.18
, pp. 2534-2542
-
-
Neugut, A.I.1
Subar, M.2
Wilde, E.T.3
Stratton, S.4
Brouse, C.H.5
Hillyer, G.C.6
-
6
-
-
77957936884
-
Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients
-
PID: 20585090
-
Hershman DL, Kushi LH, Shao T, Buono D, Kershenbaum A, Tsai WY, et al. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol. 2010;28(27):4120–8. doi:10.1200/JCO.2009.25.9655.
-
(2010)
J Clin Oncol
, vol.28
, Issue.27
, pp. 4120-4128
-
-
Hershman, D.L.1
Kushi, L.H.2
Shao, T.3
Buono, D.4
Kershenbaum, A.5
Tsai, W.Y.6
-
7
-
-
56749152357
-
Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer
-
COI: 1:CAS:528:DC%2BD1cXhsVajtbrL, PID: 18985046
-
McCowan C, Shearer J, Donnan PT, Dewar JA, Crilly M, Thompson AM, et al. Cohort study examining tamoxifen adherence and its relationship to mortality in women with breast cancer. Br J Cancer. 2008;99(11):1763–8. doi:10.1038/sj.bjc.6604758.
-
(2008)
Br J Cancer
, vol.99
, Issue.11
, pp. 1763-1768
-
-
McCowan, C.1
Shearer, J.2
Donnan, P.T.3
Dewar, J.A.4
Crilly, M.5
Thompson, A.M.6
-
8
-
-
79956104201
-
Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer
-
COI: 1:CAS:528:DC%2BC3MXjtFSrtrw%3D, PID: 20803066
-
Hershman DL, Shao T, Kushi LH, Buono D, Tsai WY, Fehrenbacher L, et al. Early discontinuation and non-adherence to adjuvant hormonal therapy are associated with increased mortality in women with breast cancer. Breast Cancer Res Treat. 2011;126(2):529–37. doi:10.1007/s10549-010-1132-4.
-
(2011)
Breast Cancer Res Treat
, vol.126
, Issue.2
, pp. 529-537
-
-
Hershman, D.L.1
Shao, T.2
Kushi, L.H.3
Buono, D.4
Tsai, W.Y.5
Fehrenbacher, L.6
-
9
-
-
73749086933
-
Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy
-
PID: 19299162
-
Hadji P. Improving compliance and persistence to adjuvant tamoxifen and aromatase inhibitor therapy. Crit Rev Oncol Hematol. 2010;73(2):156–66. doi:10.1016/j.critrevonc.2009.02.001.
-
(2010)
Crit Rev Oncol Hematol
, vol.73
, Issue.2
, pp. 156-166
-
-
Hadji, P.1
-
10
-
-
0035863386
-
Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women
-
COI: 1:CAS:528:DC%2BD3MXhtVektrk%3D, PID: 11208822
-
Demissie S, Silliman RA, Lash TL. Adjuvant tamoxifen: predictors of use, side effects, and discontinuation in older women. J Clin Oncol. 2001;19(2):322–8.
-
(2001)
J Clin Oncol
, vol.19
, Issue.2
, pp. 322-328
-
-
Demissie, S.1
Silliman, R.A.2
Lash, T.L.3
-
11
-
-
70249110823
-
Adjuvant hormonal therapy use among insured, low-income women with breast cancer
-
PID: 19451445
-
Kimmick G, Anderson R, Camacho F, Bhosle M, Hwang W, Balkrishnan R. Adjuvant hormonal therapy use among insured, low-income women with breast cancer. J Clin Oncol. 2009;27(21):3445–51. doi:10.1200/JCO.2008.19.2419.
-
(2009)
J Clin Oncol
, vol.27
, Issue.21
, pp. 3445-3451
-
-
Kimmick, G.1
Anderson, R.2
Camacho, F.3
Bhosle, M.4
Hwang, W.5
Balkrishnan, R.6
-
12
-
-
84864452219
-
Initiation of adjuvant hormone therapy by Medicaid insured women with nonmetastatic breast cancer
-
PID: 22773822
-
Yung RL, Hassett MJ, Chen K, Gesten FC, Roohan PJ, Boscoe FP, et al. Initiation of adjuvant hormone therapy by Medicaid insured women with nonmetastatic breast cancer. J Natl Cancer Inst. 2012;104(14):1102–5. doi:10.1093/jnci/djs273.
-
(2012)
J Natl Cancer Inst
, vol.104
, Issue.14
, pp. 1102-1105
-
-
Yung, R.L.1
Hassett, M.J.2
Chen, K.3
Gesten, F.C.4
Roohan, P.J.5
Boscoe, F.P.6
-
13
-
-
84856230195
-
Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer
-
PID: 21922245
-
Livaudais JC, Hershman DL, Habel L, Kushi L, Gomez SL, Li CI, et al. Racial/ethnic differences in initiation of adjuvant hormonal therapy among women with hormone receptor-positive breast cancer. Breast Cancer Res Treat. 2011;131(2):607–17. doi:10.1007/s10549-011-1762-1.
-
(2011)
Breast Cancer Res Treat
, vol.131
, Issue.2
, pp. 607-617
-
-
Livaudais, J.C.1
Hershman, D.L.2
Habel, L.3
Kushi, L.4
Gomez, S.L.5
Li, C.I.6
-
14
-
-
77951123003
-
Women’s perceptions and experience of adjuvant tamoxifen therapy account for their adherence: breast cancer patients’ point of view
-
PID: 19507263
-
Pellegrini I, Sarradon-Eck A, Soussan PB, Lacour AC, Largillier R, Tallet A, et al. Women’s perceptions and experience of adjuvant tamoxifen therapy account for their adherence: breast cancer patients’ point of view. Psychooncology. 2010;19(5):472–9. doi:10.1002/pon.1593.
-
(2010)
Psychooncology
, vol.19
, Issue.5
, pp. 472-479
-
-
Pellegrini, I.1
Sarradon-Eck, A.2
Soussan, P.B.3
Lacour, A.C.4
Largillier, R.5
Tallet, A.6
-
15
-
-
79958709842
-
Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer
-
COI: 1:CAS:528:DC%2BC3MXjtFSrtrc%3D, PID: 21249443
-
Dent SF, Gaspo R, Kissner M, Pritchard KI. Aromatase inhibitor therapy: toxicities and management strategies in the treatment of postmenopausal women with hormone-sensitive early breast cancer. Breast Cancer Res Treat. 2011;126(2):295–310. doi:10.1007/s10549-011-1351-3.
-
(2011)
Breast Cancer Res Treat
, vol.126
, Issue.2
, pp. 295-310
-
-
Dent, S.F.1
Gaspo, R.2
Kissner, M.3
Pritchard, K.I.4
-
16
-
-
39149111976
-
Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer
-
COI: 1:CAS:528:DC%2BD1cXis1alsrc%3D, PID: 18180462
-
Partridge AH, LaFountain A, Mayer E, Taylor BS, Winer E, Asnis-Alibozek A. Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol. 2008;26(4):556–62. doi:10.1200/jco.2007.11.5451.
-
(2008)
J Clin Oncol
, vol.26
, Issue.4
, pp. 556-562
-
-
Partridge, A.H.1
LaFountain, A.2
Mayer, E.3
Taylor, B.S.4
Winer, E.5
Asnis-Alibozek, A.6
-
17
-
-
0037441639
-
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer
-
COI: 1:CAS:528:DC%2BD2cXpsVGrtbs%3D, PID: 12586795
-
Partridge AH, Wang PS, Winer EP, Avorn J. Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol. 2003;21(4):602–6.
-
(2003)
J Clin Oncol
, vol.21
, Issue.4
, pp. 602-606
-
-
Partridge, A.H.1
Wang, P.S.2
Winer, E.P.3
Avorn, J.4
-
18
-
-
84879073660
-
Is medical home enrollment associated with receipt of guideline-concordant follow-up care among low-income breast cancer survivors?
-
PID: 23673393
-
Wheeler SB, Kohler RE, Goyal RK, Lich KH, Lin C-C, Moore A, et al. Is medical home enrollment associated with receipt of guideline-concordant follow-up care among low-income breast cancer survivors? Med Care. 2013;51(6):494–502. doi:10.1097/MLR.0b013e31828d4d0c.
-
(2013)
Med Care
, vol.51
, Issue.6
, pp. 494-502
-
-
Wheeler, S.B.1
Kohler, R.E.2
Goyal, R.K.3
Lich, K.H.4
Lin, C.-C.5
Moore, A.6
-
19
-
-
33750935710
-
American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting
-
PID: 17033037
-
Khatcheressian JL, Wolff AC, Smith TJ, Grunfeld E, Muss HB, Vogel VG, et al. American Society of Clinical Oncology 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol. 2006;24(31):5091–7. doi:10.1200/JCO.2006.08.8575.
-
(2006)
J Clin Oncol
, vol.24
, Issue.31
, pp. 5091-5097
-
-
Khatcheressian, J.L.1
Wolff, A.C.2
Smith, T.J.3
Grunfeld, E.4
Muss, H.B.5
Vogel, V.G.6
-
20
-
-
81755181772
-
Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over time
-
COI: 1:STN:280:DC%2BC38zltVWhsg%3D%3D, PID: 21788360
-
Cluze C, Rey D, Huiart L, BenDiane MK, Bouhnik AD, Berenger C, et al. Adjuvant endocrine therapy with tamoxifen in young women with breast cancer: determinants of interruptions vary over time. Ann Oncol. 2012;23(4):882–90. doi:10.1093/annonc/mdr330.
-
(2012)
Ann Oncol
, vol.23
, Issue.4
, pp. 882-890
-
-
Cluze, C.1
Rey, D.2
Huiart, L.3
BenDiane, M.K.4
Bouhnik, A.D.5
Berenger, C.6
-
21
-
-
33748522756
-
Side effects of aromatase inhibitors versus tamoxifen: the patients’ perspective
-
COI: 1:CAS:528:DC%2BD28Xps1Cltb0%3D, PID: 16978958
-
Garreau JR, Delamelena T, Walts D, Karamlou K, Johnson N. Side effects of aromatase inhibitors versus tamoxifen: the patients’ perspective. Am J Surg. 2006;192(4):496–8. doi:10.1016/j.amjsurg.2006.06.018.
-
(2006)
Am J Surg
, vol.192
, Issue.4
, pp. 496-498
-
-
Garreau, J.R.1
Delamelena, T.2
Walts, D.3
Karamlou, K.4
Johnson, N.5
-
22
-
-
34247354217
-
Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use
-
PID: 17446829
-
Kahn KL, Schneider EC, Malin JL, Adams JL, Epstein AM. Patient centered experiences in breast cancer: predicting long-term adherence to tamoxifen use. Med Care. 2007;45(5):431–9. doi:10.1097/01.mlr.0000257193.10760.7f.
-
(2007)
Med Care
, vol.45
, Issue.5
, pp. 431-439
-
-
Kahn, K.L.1
Schneider, E.C.2
Malin, J.L.3
Adams, J.L.4
Epstein, A.M.5
-
23
-
-
40349097819
-
Treatment variation by insurance status for breast cancer patients
-
PID: 18315690
-
Coburn N, Fulton J, Pearlman DN, Law C, DiPaolo B, Cady B. Treatment variation by insurance status for breast cancer patients. Breast J. 2008;14(2):128–34. doi:10.1111/j.1524-4741.2007.00542.x.
-
(2008)
Breast J
, vol.14
, Issue.2
, pp. 128-134
-
-
Coburn, N.1
Fulton, J.2
Pearlman, D.N.3
Law, C.4
DiPaolo, B.5
Cady, B.6
-
24
-
-
41749092567
-
Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998–2005)
-
PID: 18364506
-
Chen AY, Halpern MT, Schrag NM, Stewart A, Leitch M, Ward E. Disparities and trends in sentinel lymph node biopsy among early-stage breast cancer patients (1998–2005). J Natl Cancer Inst. 2008;100(7):462–74.
-
(2008)
J Natl Cancer Inst
, vol.100
, Issue.7
, pp. 462-474
-
-
Chen, A.Y.1
Halpern, M.T.2
Schrag, N.M.3
Stewart, A.4
Leitch, M.5
Ward, E.6
-
25
-
-
32444442071
-
The effect of race/ethnicity and insurance in the administration of standard therapy for local breast cancer in Florida
-
PID: 16244785
-
Voti L, Richardson LC, Reis I, Fleming LE, Mackinnon J, Coebergh JW. The effect of race/ethnicity and insurance in the administration of standard therapy for local breast cancer in Florida. Breast Cancer Res Treat. 2006;95(1):89–95.
-
(2006)
Breast Cancer Res Treat
, vol.95
, Issue.1
, pp. 89-95
-
-
Voti, L.1
Richardson, L.C.2
Reis, I.3
Fleming, L.E.4
Mackinnon, J.5
Coebergh, J.W.6
-
26
-
-
34447285278
-
Lost opportunities: physicians’ reasons and disparities in breast cancer treatment
-
PID: 17577028
-
Bickell NA, LePar F, Wang JJ, Leventhal H. Lost opportunities: physicians’ reasons and disparities in breast cancer treatment. J Clin Oncol. 2007;25(18):2516–21.
-
(2007)
J Clin Oncol
, vol.25
, Issue.18
, pp. 2516-2521
-
-
Bickell, N.A.1
LePar, F.2
Wang, J.J.3
Leventhal, H.4
-
27
-
-
80053654178
-
Caring for survivors of breast cancer: perspective of the primary care physician
-
COI: 1:STN:280:DC%2BC3MfptlOhsA%3D%3D, PID: 21980253
-
Smith SL, Wai ES, Alexander C, Singh-Carlson S. Caring for survivors of breast cancer: perspective of the primary care physician. Curr Oncol. 2011;18(5):e218–26.
-
(2011)
Curr Oncol
, vol.18
, Issue.5
, pp. e218-e226
-
-
Smith, S.L.1
Wai, E.S.2
Alexander, C.3
Singh-Carlson, S.4
-
28
-
-
71549137422
-
Survivorship: adult cancer survivors
-
PID: 19913184
-
Ganz PA. Survivorship: adult cancer survivors. Prim Care. 2009;36(4):721–41. doi:10.1016/j.pop.2009.08.001.
-
(2009)
Prim Care
, vol.36
, Issue.4
, pp. 721-741
-
-
Ganz, P.A.1
-
29
-
-
83655201442
-
Differences between primary care physicians’ and oncologists’ knowledge, attitudes and practices regarding the care of cancer survivors
-
PID: 21785923
-
Potosky A, Han PJ, Rowland J, Klabunde C, Smith T, Aziz N, et al. Differences between primary care physicians’ and oncologists’ knowledge, attitudes and practices regarding the care of cancer survivors. J Gen Intern Med. 2011;26(12):1403–10. doi:10.1007/s11606-011-1808-4.
-
(2011)
J Gen Intern Med
, vol.26
, Issue.12
, pp. 1403-1410
-
-
Potosky, A.1
Han, P.J.2
Rowland, J.3
Klabunde, C.4
Smith, T.5
Aziz, N.6
-
30
-
-
84855361967
-
Do Survivorship care plans make a difference? A primary care provider perspective
-
PID: 22211129
-
Shalom MM, Hahn EE, Casillas J, Ganz PA. Do Survivorship care plans make a difference? A primary care provider perspective. J Oncol Pract. 2011;7(5):314–8. doi:10.1200/JOP.2010.000208.
-
(2011)
J Oncol Pract
, vol.7
, Issue.5
, pp. 314-318
-
-
Shalom, M.M.1
Hahn, E.E.2
Casillas, J.3
Ganz, P.A.4
-
31
-
-
0037012339
-
Race, socioeconomic status, and breast cancer treatment and survival
-
PID: 11929949
-
Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94(7):490–6. doi:10.1093/jnci/94.7.490.
-
(2002)
J Natl Cancer Inst
, vol.94
, Issue.7
, pp. 490-496
-
-
Bradley, C.J.1
Given, C.W.2
Roberts, C.3
-
32
-
-
0036841321
-
Race, socioeconomic status, and breast carcinoma in the U.S: what have we learned from clinical studies
-
PID: 12404294
-
Cross CK, Harris J, Recht A. Race, socioeconomic status, and breast carcinoma in the U.S: what have we learned from clinical studies. Cancer. 2002;95(9):1988–99.
-
(2002)
Cancer
, vol.95
, Issue.9
, pp. 1988-1999
-
-
Cross, C.K.1
Harris, J.2
Recht, A.3
|